GT Biopharma (GTBP) had the highest return between 2011 and 2013 by a US stock, returning 81,832,250.9%.
| ASSET | YEARS | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2011-2013 | 81,832,250.93% |
Sequans Communications (SQNS) | 2011-2013 | 2,409,538.55% |
QXO (QXO) | 2011-2013 | 2,352,000% |
Nutex Health (NUTX) | 2011-2013 | 749,900.2% |
Castellum (CTM) | 2011-2013 | 469,465.22% |
Kartoon Studios (TOON) | 2011-2013 | 44,900% |
BioLineRx (BLRX) | 2011-2013 | 27,132.64% |
Nixxy (NIXX) | 2011-2013 | 14,300% |
Xpel (XPEL) | 2011-2013 | 7,022.22% |
Actinium Pharmaceuticals (ATNM) | 2011-2013 | 5,254.54% |
Par Pacific (PARR) | 2011-2013 | 3,616.67% |
Natural Health Trend (NHTC) | 2011-2013 | 3,454.46% |
Nova Lifestyle I (NVFY) | 2011-2013 | 2,906.67% |
Kazia Therapeutics Ltd ADR (KZIA) | 2011-2013 | 2,138.07% |
ACADIA Pharmaceuticals (ACAD) | 2011-2013 | 2,000% |
Coda Octopus (CODA) | 2011-2013 | 1,707.69% |
Fonar (FONR) | 2011-2013 | 1,544.19% |
Supercom (SPCB) | 2011-2013 | 1,452.97% |
Patrick Industries (PATK) | 2011-2013 | 1,339.31% |
Vipshop (VIPS) | 2011-2013 | 1,294.64% |
DarioHealth (DRIO) | 2011-2013 | 1,250% |
Where Food Comes From (WFCF) | 2011-2013 | 1,149.97% |
Barfresh Food (BRFH) | 2011-2013 | 1,140% |
Intellinetics (INLX) | 2011-2013 | 1,066.67% |
Puma Biotechnology (PBYI) | 2011-2013 | 935.3% |
